{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-020590","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.188734+00:00","generated_at":"2026-06-01T03:51:20.313918+00:00","sec_items":["1.01","2.03","7.01","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aytu refinances $15M term loan to $13M at ~12.4%, saving $1.3M interest","bullets":["New $13M Eclipse term loan at SOFR+7% (~12.4%), replacing $15M Avenue loan at ~15.9%.","Interest rate reduced ~350 bps, saving ~$1.3M over loan life; maturity extended to June 2028.","Revolving credit facility extended to June 2028 with max borrowing capacity increased to $14.5M.","Received $3.5M from exercise of 2.17M warrants at $1.59; $2M used to pay down term loan.","Shares outstanding 5,972,327 as of June 18, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-020590","json":"https://secwatch.observer/filing/0001437749-24-020590.json","markdown":"https://secwatch.observer/filing/0001437749-24-020590.md","text":"https://secwatch.observer/filing/0001437749-24-020590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774924020590/0001437749-24-020590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774924020590/aytu20240607c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:51:20.313918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}